Cargando…

Impact of different therapies on the survival of patients with stage I–IIA cervical cancer with intermediate risk factors

BACKGROUND: The aim of this study was to determine the effects of different therapies on patients with cervical cancer (CC) with intermediate risk factors. METHODS: Clinicopathological data of 596 patients diagnosed with stage I–IIA CC at the Obstetrics and Gynecology Hospital of Fudan University be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Jichan, Wu, Qinjiao, Yan, Anqi, Wu, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867952/ https://www.ncbi.nlm.nih.gov/pubmed/33569444 http://dx.doi.org/10.21037/atm-20-7679

Ejemplares similares

Diagnosis-to-surgery interval and survival for different histologies of stage I–IIA lung cancer
por: Zhang, Lu, et al.
Publicado: (2021)

RETRACTED ARTICLE: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY
por: Yan, Anqi, et al.
Publicado: (2020)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer
por: Wu, San-Gang, et al.
Publicado: (2017)

Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer
por: Ratosa, Ivica, et al.
Publicado: (2021)

Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer
por: Senchukova, Marina A., et al.
Publicado: (2020)

Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer
por: Zhang, Weifeng, et al.
Publicado: (2019)

The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa–IVa lower thoracic oesophageal squamous cell carcinoma
por: Wang, Yichun, et al.
Publicado: (2018)

Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
por: Sun, Hai-Yan, et al.
Publicado: (2018)

Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching
por: Yan, Han, et al.
Publicado: (2022)

Pretreatment C‐reactive protein/albumin ratio is associated with poor survival in patients with stage IB‐IIA cervical cancer
por: Zhang, Weiwei, et al.
Publicado: (2017)

Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study
por: Ouyang, Peilin, et al.
Publicado: (2020)

Microscopical Variables and Tumor Inflammatory Microenvironment Do Not Modify Survival or Recurrence in Stage I-IIA Lung Adenocarcinomas
por: Dell’Amore, Andrea, et al.
Publicado: (2023)

Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis
por: Cheng, Jing, et al.
Publicado: (2021)

Human papillomavirus 18 as a poor prognostic factor in stage I-IIA cervical cancer following primary surgical treatment
por: Yang, Sun-Hye, et al.
Publicado: (2014)

Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study
por: Mo, Shaobo, et al.
Publicado: (2018)

Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma
por: Dai, Yi-Fang, et al.
Publicado: (2018)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Screening of prognostic immune genes and establishment of prognostic model of cervical adenocarcinoma based on bioinformatics analysis
por: Yi, Yunhua, et al.
Publicado: (2022)

Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer
por: Zhou, Juan, et al.
Publicado: (2015)

Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa
por: Villadiego-Sánchez, J.M., et al.
Publicado: (2009)

Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma
por: Lu, Yanwei, et al.
Publicado: (2021)

Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer
por: Wang, Shan, et al.
Publicado: (2023)

Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
por: Gaffney, David K.
Publicado: (2012)

Therapy of clinical stage IIA and IIB seminoma: a systematic review
por: Heinzelbecker, Julia, et al.
Publicado: (2021)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
por: Huang, Yuhui, et al.
Publicado: (2022)

Predictive value of hemoglobin, platelets, and D-dimer for the survival of patients with stage IA1 to IIA2 cervical cancer: a retrospective study
por: Li, Bilan, et al.
Publicado: (2021)

Concurrent Learning Curves of 3-Dimensional and Robotic-Assisted Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer Using 2-Dimensional Laparoscopic Radical Hysterectomy as a Benchmark: A Single Surgeon’s Experience
por: Ding, Ding, et al.
Publicado: (2019)

Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016
por: Chen, Chunlin, et al.
Publicado: (2021)

Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2020)

Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Whole-tumor histogram analysis of apparent diffusion coefficients for predicting lymphovascular space invasion in stage IB-IIA cervical cancer
por: Cheng, Jin-mei, et al.
Publicado: (2023)

The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer
por: Zhang, Can, et al.
Publicado: (2019)

Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
por: Zhou, Fang, et al.
Publicado: (2022)

Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study
por: Yan, Wenxing, et al.
Publicado: (2020)

Predicting MicroRNA Target Genes and Identifying Hub Genes in IIA Stage Colon Cancer Patients Using Bioinformatics Analysis
por: Dong, Zhiyong, et al.
Publicado: (2019)

Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study
por: Guo, Qinhao, et al.
Publicado: (2021)

Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer
por: Jiang, Yinan, et al.
Publicado: (2021)

The relevance of plasma R-spondin 1 and Slit2 as predictive biomarkers in cervical cancer chemotherapy and radiotherapy
por: Nie, Jichan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_011kqpv6a8gf6saik0i2c731m9